The present and future management of malignant brain tumours: surgery, radiotherapy, chemotherapy.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

24 citing papers in PubMed, 4 syntheses or guidelines pooled it.

1. Biopsy versus resection for high-grade glioma.The Cochrane database of systematic reviews · 2019
   Pooled it
2. Temozolomide for high grade glioma.The Cochrane database of systematic reviews · 2013
   Pooled it
3. Chemotherapy wafers for high grade glioma.The Cochrane database of systematic reviews · 2011
   Pooled it
4. Biopsy versus resection for malignant glioma.The Cochrane database of systematic reviews · 2000
   Pooled it
5. Protective Impacts ofLife (Basel, Switzerland) · 2025
   Article
6. Advancing CNS Therapeutics: Enhancing Neurological Disorders with Nanoparticle-Based Gene and Enzyme Replacement Therapies.International journal of nanomedicine · 2025
   Review
7. Dosimetric evaluation and treatment planning considerations for GammaTile permanent brain implants - a pilot, institutional experience.Journal of neuro-oncology · 2024
   Article
8. Dosimetric Impact of Source Displacement in GammaTile Surgically Targeted Radiation Therapy for Gliomas.Cureus · 2023
   Article
9. Lipid nanostructures for targeting brain cancer.Heliyon · 2021
   Review
10. Non-coplanar VMAT plans for postoperative primary brain tumour to reduce dose to hippocampus, temporal lobe and cochlea: a planning study.BJR open · 2021
    Article
11. Recent advances in drug delivery systems for enhancing drug penetration into tumors.Drug delivery · 2020
    Review
12. Supramolecular Tripeptide Hydrogel Assembly with 5-Fluorouracil.Gels (Basel, Switzerland) · 2019
    Article
13. Synthesis of Selenium-Quinone Hybrid Compounds with Potential Antitumor Activity via Rh-Catalyzed C-H Bond Activation and Click Reactions.Molecules (Basel, Switzerland) · 2017
    Article
14. Diagnostic accuracy of proton magnetic resonance spectroscopy and perfusion-weighted imaging in brain gliomas follow-up: a single institutional experience.The neuroradiology journal · 2017
    Article
15. Post-operative diffusion weighted imaging as a predictor of posterior fossa syndrome permanence in paediatric medulloblastoma.Child's nervous system : ChNS : official journal of the International Society for Pediatric Neurosurgery · 2017
    Article
16. Knocking down the expression of SYF2 inhibits the proliferation of glioma cells.Medical oncology (Northwood, London, England) · 2014
    Article
17. Ubiquitin-specific protease 22: a novel molecular biomarker in glioma prognosis and therapeutics.Medical oncology (Northwood, London, England) · 2014
    Article
18. ID1 regulates U87 human cell proliferation and invasion.Oncology letters · 2013
    Article
19. Bex2 is critical for migration and invasion in malignant glioma cells.Journal of molecular neuroscience : MN · 2013
    Article
20. NEDD4-1 regulates migration and invasion of glioma cells through CNrasGEF ubiquitination in vitro.PloS one · 2013
    Article

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

Authors and funding

3 authors.

Funding

No grant is acknowledged in the PubMed record.

Abstract

PubMed holds no abstract for this paper.

Indexed as